A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors	Solid Tumor	Recruiting	Phase 1	2025-12-30		NCT06368921

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Guangzhou Virotech Pharmaceutical Co., Ltd.	8

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Cancer Hospital of Shandong First Medical University	Jinan	China	3
Affiliated Cancer Hospital of Zhengzhou University	Zhengzhou	China	1
Sun Yat-Sen University Cancer Center	Guangzhou	China	113

Clinical trials